| pubmed-article:19449227 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0033085 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0023078 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C1335579 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:19449227 | lifeskim:mentions | umls-concept:C0521115 | lld:lifeskim |
| pubmed-article:19449227 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19449227 | pubmed:dateCreated | 2010-6-14 | lld:pubmed |
| pubmed-article:19449227 | pubmed:abstractText | Conventional radiotherapy with concurrent cisplatin is significantly superior to induction cisplatin fluorouracil chemotherapy followed by radiotherapy in terms of laryngeal preservation in patients with T3 hypopharyngeal carcinoma. Despite a high rate of laryngeal preservation no survival benefit was recorded in this selected population. | lld:pubmed |
| pubmed-article:19449227 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19449227 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19449227 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19449227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19449227 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19449227 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19449227 | pubmed:issn | 1651-2251 | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:PradesJean-Mi... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:TimoshenkoAnd... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:ReytEmileE | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:GuerrierBerna... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:LallemantBenj... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:SchmittThierr... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:GarrelRenaudR | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:TrombertBeatr... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:RighiniChrist... | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:ReminiNagibN | lld:pubmed |
| pubmed-article:19449227 | pubmed:author | pubmed-author:Saban-RocheLe... | lld:pubmed |
| pubmed-article:19449227 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19449227 | pubmed:volume | 130 | lld:pubmed |
| pubmed-article:19449227 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19449227 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19449227 | pubmed:pagination | 150-5 | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:meshHeading | pubmed-meshheading:19449227... | lld:pubmed |
| pubmed-article:19449227 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19449227 | pubmed:articleTitle | Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma. | lld:pubmed |
| pubmed-article:19449227 | pubmed:affiliation | Department of Otolaryngology - Head and Neck Surgery, Saint-Etienne University Hospital Center, Loire Cancer Institute, Saint-Etienne, France. | lld:pubmed |
| pubmed-article:19449227 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19449227 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:19449227 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:19449227 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:19449227 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
